Get the Stockscreener App
0.00
100.00%
-1.21
Rain Oncology Inc Stock (RAIN) Forecast
The Rain Oncology Inc (RAIN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.1325, representing a + increase from the current price of $0.00. The highest analyst price target is $0.3862, and the lowest is $1.8787.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RAIN Price Target
Average 5.2877
(+ Upside)
Is Rain Oncology Inc (RAIN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 5.81 | Buy |
| STOCH(9,6) | 50.26 | Neutral |
| STOCHRSI(14) | 58.42 | Neutral |
| MACD(12,26) | -0.0822 | Sell |
| ADX(14) | 37.45 | Sell |
| William %R | -100.00 | Buy |
| CCI(14) | -466.67 | Sell |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.096
Sell
|
0.9963
Sell
|
| MA20 |
1.149
Sell
|
1.0927
Sell
|
| MA50 |
1.1404
Sell
|
1.1287
Sell
|
| MA100 |
1.0524
Sell
|
1.3526
Sell
|
| MA200 |
2.106
Sell
|
2.9489
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, RAIN could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 13 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on RAIN, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 5.81 indicates that RAIN is oversold. This indicates that RAIN price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 50.26 indicates that RAIN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 58.42 indicates that RAIN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 37.45 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -466.67 indicates that RAIN is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term RAIN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Rain Oncology Inc financial reports and earnings history, Rain Oncology Inc (RAIN) stock could reach $32.37 by 2030, $16.24 by 2040 and $69.98 by 2050. See the projected annual prices until 2050 of the Rain Oncology Inc stock below:
- Rain Oncology Inc (RAIN) is expected to reach an average price of $61.45 in 2035, with a high prediction of $61.79 and a low estimate of $62.37. This indicates an $ rise from the last recorded price of $0.00.
- Rain Oncology Inc (RAIN) stock is projected to chart a bullish course in 2040, with an average price target of $13.54, representing an $ surge from its current level. The forecast ranges from a conservative $13.57 to a sky-high $16.24.
- Our analysts predict Rain Oncology Inc (RAIN) to jump by 2045, soaring from $31.86 to an average price of $38.09, potentially reaching $38.26. While $31.86 is the low estimate, the potential upside is significant.
- Rain Oncology Inc (RAIN) stock is expected to climb by 2050, reaching an average of $63.85, a $ jump from its current level. However, a wide range of estimates exists, with high and low targets of $69.98 and $66.14, respectively, highlighting the market's uncertainty.
Rain Oncology Inc Stock (RAIN) Year by Year Forecast
Rain Oncology Inc Stock (RAIN) Price Forecast for 2024
Our forecast for RAIN stock price in 2024 now indicates an average price target of $4.5023 with a high forecast of $8.6968 and a low forecast of $0.3078. The average prediction reflects an increase of + from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $0.0865 | $1.8787 | $0.3862 | + |
| June, 2024 | $4.5133 | $2.116 | $1.9033 | + |
| July, 2024 | $6.2954 | $5.1881 | $5.2154 | + |
| August, 2024 | $5.9352 | $7.0703 | $6.6453 | + |
| September, 2024 | $7.9273 | $6.3776 | $6.5425 | + |
| October, 2024 | $8.7671 | $7.9846 | $7.4271 | + |
| November, 2024 | $8.9268 | $8.9918 | $8.6968 | + |
| December, 2024 | $5.149 | $7.254 | $8.1541 | + |
Rain Oncology Inc Stock (RAIN) Price Forecast for 2025
Rain Oncology Inc Stock (RAIN) is expected to reach an average price of $3.7199 in 2025, with a high prediction of $7.2131 and a low estimate of $0.2266. This indicates an + rise from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $3.8287 | $4.5887 | $4.8138 | + |
| February, 2025 | $3.9085 | $2.676 | $2.5212 | + |
| March, 2025 | $2.9806 | $3.5443 | $3.5458 | + |
| April, 2025 | $4.0104 | $3.9731 | $3.4879 | + |
| May, 2025 | $2.5501 | $2.8501 | $3.2628 | + |
| June, 2025 | $0.0777 | $0.4623 | $1.8425 | + |
| July, 2025 | $0.518 | $0.8671 | $0.7768 | + |
| August, 2025 | $2.9683 | $0.2266 | $7.2131 | + |
| September, 2025 | $1.9861 | $1.3861 | $4.6985 | + |
| October, 2025 | $1.7564 | $1.0264 | $3.4288 | + |
| November, 2025 | $1.7966 | $1.2691 | $3.2315 | + |
| December, 2025 | $4.8145 | $1.0018 | $5.3945 | + |
Rain Oncology Inc Stock (RAIN) Price Forecast for 2026
The predicted value for Rain Oncology Inc (RAIN) in 2026 is set at an average of $7.8408. Estimates vary from a peak of $15.63 to a trough of $0.0531, indicating an + surge from the present price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.4453 | $3.4903 | $3.7604 | + |
| February, 2026 | $3.135 | $3.1726 | $3.2177 | + |
| March, 2026 | $2.4672 | $2.4972 | $2.8274 | + |
| April, 2026 | $2.2369 | $2.2969 | $2.372 | + |
| May, 2026 | $2.011 | $2.0216 | $2.1193 | + |
| June, 2026 | $1.2488 | $1.3098 | $1.8756 | + |
| July, 2026 | $0.7885 | $0.8585 | $1.1312 | + |
| August, 2026 | $0.1507 | $0.2556 | $0.681 | + |
| September, 2026 | $14.73 | $0.0531 | $14.88 | + |
| October, 2026 | $15.65 | $14.46 | $14.44 | + |
| November, 2026 | $15.77 | $16.04 | $15.39 | + |
| December, 2026 | $13.50 | $14.22 | $15.63 | + |
Rain Oncology Inc Stock (RAIN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Rain Oncology Inc (RAIN) is $16.29, with a high forecast of $19.94 and a low forecast of $12.63. This indicates an + increase from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $16.24 | $14.00 | $14.75 | + |
| February, 2027 | $14.99 | $16.05 | $14.03 | + |
| March, 2027 | $18.22 | $16.00 | $18.15 | + |
| April, 2027 | $19.60 | $19.03 | $19.20 | + |
| May, 2027 | $19.09 | $18.92 | $19.51 | + |
| June, 2027 | $19.25 | $19.33 | $19.10 | + |
| July, 2027 | $20.59 | $19.77 | $19.58 | + |
| August, 2027 | $19.56 | $19.64 | $19.94 | + |
| September, 2027 | $15.82 | $16.84 | $19.08 | + |
| October, 2027 | $13.92 | $14.29 | $15.31 | + |
| November, 2027 | $13.34 | $12.63 | $12.50 | + |
| December, 2027 | $11.81 | $12.85 | $13.07 | + |
Rain Oncology Inc Stock (RAIN) Price Forecast for 2028
In 2028, Rain Oncology Inc (RAIN) is projected to reach an average price of $6.8197, with a high projection of $12.48 and a low estimate of $1.1636. This indicates an + rise from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $11.34 | $12.31 | $12.48 | + |
| February, 2028 | $9.6699 | $10.47 | $11.18 | + |
| March, 2028 | $8.5994 | $8.3745 | $8.0505 | + |
| April, 2028 | $4.8589 | $7.1479 | $7.7291 | + |
| May, 2028 | $3.9232 | $4.5837 | $3.6935 | + |
| June, 2028 | $3.8627 | $4.3327 | $3.7247 | + |
| July, 2028 | $2.997 | $3.4675 | $3.1107 | + |
| August, 2028 | $3.8465 | $3.9266 | $3.4205 | + |
| September, 2028 | $8.9159 | $1.1636 | $8.2159 | + |
| October, 2028 | $7.6303 | $7.7203 | $8.6608 | + |
| November, 2028 | $6.6597 | $6.8219 | $7.4251 | + |
| December, 2028 | $6.0992 | $6.1192 | $6.4446 | + |
Rain Oncology Inc Stock (RAIN) Price Forecast for 2029
The 2029 price forecast for Rain Oncology Inc Stock (RAIN) is $16.42 on average, with a high prediction of $31.54 and a low estimate of $1.2963. This represents an + increase from the previous price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.2155 | $5.2286 | $5.8741 | + |
| February, 2029 | $4.409 | $4.463 | $4.9785 | + |
| March, 2029 | $3.3525 | $3.3925 | $4.0684 | + |
| April, 2029 | $2.2968 | $2.3568 | $3.0773 | + |
| May, 2029 | $1.654 | $1.2963 | $2.0117 | + |
| June, 2029 | $30.73 | $31.33 | $31.19 | + |
| July, 2029 | $31.58 | $30.44 | $30.65 | + |
| August, 2029 | $31.38 | $31.49 | $30.84 | + |
| September, 2029 | $28.46 | $28.69 | $28.86 | + |
| October, 2029 | $30.46 | $29.86 | $29.12 | + |
| November, 2029 | $29.23 | $29.83 | $27.94 | + |
| December, 2029 | $32.06 | $31.88 | $31.54 | + |
Rain Oncology Inc Stock (RAIN) Price Forecast for 2030
Rain Oncology Inc Stock (RAIN) is expected to reach an average price of $24.31 in 2030, with a high forecast of $32.37 and a low forecast of $16.26. This signifies an + surge from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $32.97 | $32.55 | $32.37 | + |
| February, 2030 | $31.90 | $31.45 | $31.19 | + |
| March, 2030 | $31.55 | $31.54 | $31.10 | + |
| April, 2030 | $31.56 | $31.55 | $31.39 | + |
| May, 2030 | $30.45 | $30.59 | $31.19 | + |
| June, 2030 | $26.46 | $26.84 | $28.06 | + |
| July, 2030 | $21.86 | $22.59 | $25.30 | + |
| August, 2030 | $23.08 | $23.06 | $22.60 | + |
| September, 2030 | $22.66 | $22.17 | $21.75 | + |
| October, 2030 | $19.95 | $20.17 | $20.86 | + |
| November, 2030 | $16.38 | $17.58 | $18.96 | + |
| December, 2030 | $16.28 | $16.26 | $16.07 | + |
1.53%
3.38%
Cap:
|
Volume (24h):